Literature DB >> 11708488

Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: evidence for a preferential release from viable cells?

M Stroun1, J Lyautey, C Lederrey, H E Mulcahy, P Anker.   

Abstract

Small amounts of DNA circulate freely in plasma or serum, but the mechanism of release is not known. To determine if DNA is actively excreted from viable cells, we utilized real-time PCR to measure the proportion of Alu repeat sequences compared to the beta-globin gene in serum and lymphocyte DNA in 27 cancer patients and 22 healthy controls. The proportion of Alu compared to beta-globin was significantly greater in serum DNA than in lymphocyte DNA both in control subjects (p = 0.003) and in cancer patients (p < 0.001). Overall, the proportion was similar in cancer and control patients (p = 0.79). Further experiments showed that the beta-globin gene was not more vulnerable to degradation by nuclease action than Alu sequences. Our results lead us to conclude that active DNA release is likely to play a significant role in the origin of circulating DNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708488     DOI: 10.1111/j.1749-6632.2001.tb03894.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

Review 1.  Promiscuous DNA: horizontal transfer of transposable elements and why it matters for eukaryotic evolution.

Authors:  Sarah Schaack; Clément Gilbert; Cédric Feschotte
Journal:  Trends Ecol Evol       Date:  2010-06-28       Impact factor: 17.712

2.  Bov-tA short interspersed nucleotide element sequences in circulating nucleic acids from sera of cattle with bovine spongiform encephalopathy (BSE) and sera of cattle exposed to BSE.

Authors:  Ekkehard Schütz; Howard B Urnovitz; Leonid Iakoubov; Walter Schulz-Schaeffer; Wilhelm Wemheuer; Bertram Brenig
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

Review 3.  Circulating tumor cells versus circulating tumor DNA in lung cancer-which one will win?

Authors:  Silvia Calabuig-Fariñas; Eloísa Jantus-Lewintre; Alejandro Herreros-Pomares; Carlos Camps
Journal:  Transl Lung Cancer Res       Date:  2016-10

4.  Circulating nucleic acids: An analysis of their occurrence in malignancies.

Authors:  Shankar Suraj; Chirag Dhar; Sweta Srivastava
Journal:  Biomed Rep       Date:  2016-11-16

Review 5.  Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.

Authors:  André Nogueira da Costa; Zdenko Herceg
Journal:  Mol Oncol       Date:  2012-08-16       Impact factor: 6.603

Review 6.  Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids.

Authors:  Masahiro Tsujiura; Daisuke Ichikawa; Hirotaka Konishi; Shuhei Komatsu; Atsushi Shiozaki; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 7.  Liquid Biopsy in Uveal Melanoma: Are We There Yet?

Authors:  Eva Jin; Julia V Burnier
Journal:  Ocul Oncol Pathol       Date:  2020-07-29

Review 8.  Urine as a Source of Liquid Biopsy for Cancer.

Authors:  Masanori Oshi; Vijayashree Murthy; Hideo Takahashi; Michelle Huyser; Maiko Okano; Yoshihisa Tokumaru; Omar M Rashid; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

9.  Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma.

Authors:  Claudia Hd Metz; Max Scheulen; Norbert Bornfeld; Dietmar Lohmann; Michael Zeschnigk
Journal:  Cancer Med       Date:  2013-02-14       Impact factor: 4.452

10.  Plasma cell-free DNA in paediatric lymphomas.

Authors:  Lara Mussolin; Roberta Burnelli; Marta Pillon; Elisa Carraro; Piero Farruggia; Alessandra Todesco; Maurizio Mascarin; Angelo Rosolen
Journal:  J Cancer       Date:  2013-04-16       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.